Annual CFI
-$2.07 B
-$1.04 B-101.35%
31 December 2023
Summary:
Royalty Pharma annual cash flow from investing activities is currently -$2.07 billion, with the most recent change of -$1.04 billion (-101.35%) on 31 December 2023. During the last 3 years, it has risen by +$686.53 million (+24.88%). RPRX annual CFI is now -783.13% below its all-time high of $303.42 million, reached on 31 December 2018.RPRX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$1.19 B
-$299.52 M-33.53%
30 September 2024
Summary:
Royalty Pharma quarterly cash flow from investing activities is currently -$1.19 billion, with the most recent change of -$299.52 million (-33.53%) on 30 September 2024. Over the past year, it has dropped by -$742.04 million (-164.66%). RPRX quarterly CFI is now -387.58% below its all-time high of $414.74 million, reached on 31 December 2022.RPRX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$3.17 B
-$742.04 M-30.53%
30 September 2024
Summary:
Royalty Pharma TTM cash flow from investing activities is currently -$3.17 billion, with the most recent change of -$742.04 million (-30.53%) on 30 September 2024. Over the past year, it has dropped by -$2.51 billion (-382.26%). RPRX TTM CFI is now -382.26% below its all-time high of -$657.88 million, reached on 30 September 2023.RPRX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RPRX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -101.3% | -164.7% | -382.3% |
| 3 y3 years | +24.9% | -41.1% | -47.5% |
| 5 y5 years | -783.1% | -93.8% | -51.8% |
RPRX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -101.3% | +24.9% | -387.6% | +16.3% | -382.3% | at low |
| 5 y | 5 years | -783.1% | +24.9% | -387.6% | +16.3% | -382.3% | at low |
| alltime | all time | -783.1% | +24.9% | -387.6% | +16.3% | -382.3% | at low |
Royalty Pharma Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.19 B(+33.5%) | -$3.17 B(+30.5%) |
| June 2024 | - | -$893.18 M(+930.8%) | -$2.43 B(+51.8%) |
| Mar 2024 | - | -$86.65 M(-91.3%) | -$1.60 B(-22.8%) |
| Dec 2023 | -$2.07 B(+101.4%) | -$1.00 B(+121.9%) | -$2.07 B(+215.1%) |
| Sept 2023 | - | -$450.66 M(+610.4%) | -$657.88 M(-59.7%) |
| June 2023 | - | -$63.43 M(-88.6%) | -$1.63 B(+2.1%) |
| Mar 2023 | - | -$558.53 M(-234.7%) | -$1.60 B(+55.3%) |
| Dec 2022 | -$1.03 B(-45.0%) | $414.74 M(-129.1%) | -$1.03 B(-48.4%) |
| Sept 2022 | - | -$1.43 B(+4622.5%) | -$2.00 B(+40.9%) |
| June 2022 | - | -$30.18 M(-370.3%) | -$1.42 B(+12.4%) |
| Mar 2022 | - | $11.16 M(-102.0%) | -$1.26 B(-32.6%) |
| Dec 2021 | -$1.87 B | -$551.65 M(-34.8%) | -$1.87 B(-13.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$845.50 M(-770.1%) | -$2.15 B(-3.4%) |
| June 2021 | - | $126.17 M(-121.1%) | -$2.23 B(-14.3%) |
| Mar 2021 | - | -$599.30 M(-28.0%) | -$2.60 B(-5.9%) |
| Dec 2020 | -$2.76 B(+28.1%) | -$832.40 M(-9.5%) | -$2.76 B(+38.7%) |
| Sept 2020 | - | -$920.20 M(+275.6%) | -$1.99 B(+18.1%) |
| June 2020 | - | -$244.97 M(-67.8%) | -$1.68 B(+5.4%) |
| Mar 2020 | - | -$761.75 M(+1112.7%) | -$1.60 B(-25.8%) |
| Dec 2019 | -$2.15 B(-809.8%) | -$62.82 M(-89.8%) | -$2.15 B(+3.0%) |
| Sept 2019 | - | -$615.27 M(+288.5%) | -$2.09 B(+41.7%) |
| June 2019 | - | -$158.37 M(-88.0%) | -$1.48 B(+12.0%) |
| Mar 2019 | - | -$1.32 B | -$1.32 B |
| Dec 2018 | $303.42 M(-119.1%) | - | - |
| Dec 2017 | -$1.59 B | - | - |
FAQ
- What is Royalty Pharma annual cash flow from investing activities?
- What is the all time high annual CFI for Royalty Pharma?
- What is Royalty Pharma annual CFI year-on-year change?
- What is Royalty Pharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Royalty Pharma?
- What is Royalty Pharma quarterly CFI year-on-year change?
- What is Royalty Pharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for Royalty Pharma?
- What is Royalty Pharma TTM CFI year-on-year change?
What is Royalty Pharma annual cash flow from investing activities?
The current annual CFI of RPRX is -$2.07 B
What is the all time high annual CFI for Royalty Pharma?
Royalty Pharma all-time high annual cash flow from investing activities is $303.42 M
What is Royalty Pharma annual CFI year-on-year change?
Over the past year, RPRX annual cash flow from investing activities has changed by -$1.04 B (-101.35%)
What is Royalty Pharma quarterly cash flow from investing activities?
The current quarterly CFI of RPRX is -$1.19 B
What is the all time high quarterly CFI for Royalty Pharma?
Royalty Pharma all-time high quarterly cash flow from investing activities is $414.74 M
What is Royalty Pharma quarterly CFI year-on-year change?
Over the past year, RPRX quarterly cash flow from investing activities has changed by -$742.04 M (-164.66%)
What is Royalty Pharma TTM cash flow from investing activities?
The current TTM CFI of RPRX is -$3.17 B
What is the all time high TTM CFI for Royalty Pharma?
Royalty Pharma all-time high TTM cash flow from investing activities is -$657.88 M
What is Royalty Pharma TTM CFI year-on-year change?
Over the past year, RPRX TTM cash flow from investing activities has changed by -$2.51 B (-382.26%)